Here are the 8-K filings from Oncocyte Corporation (OCX) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow OCX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OCX filings page.
Insight Molecular Diagnostics Inc. filed a current report to state that it released a press release with its financial results for the six months ended June 30, 2025. The company explains that the press release, dated August 11, 2025 and attached as Exhibit 99.1, contains details on its results of operations and financial condition for that period. The information in this section is furnished rather than filed, meaning it is not subject to certain liability provisions and is not automatically incorporated into other securities law filings unless specifically referenced.